CRISPRX Trademark

Trademark Overview


On Monday, August 22, 2022, a trademark application was filed for CRISPRX with the United States Patent and Trademark Office. The USPTO has given the CRISPRX trademark a serial number of 97558002. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, May 9, 2024. This trademark is owned by CRISPR Therapeutics AG. The CRISPRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to i...
crisprx

General Information


Serial Number97558002
Word MarkCRISPRX
Filing DateMonday, August 22, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, May 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements


Goods and ServicesScientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 11, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCRISPR Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZUG V8 SWITZERLAND 6300
CH

Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZUG V8 SWITZERLAND 6300
CH

Trademark Events


Event DateEvent Description
Thursday, August 25, 2022NEW APPLICATION ENTERED
Sunday, September 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 13, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, February 13, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, March 31, 2023ASSIGNED TO EXAMINER
Friday, March 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 8, 2023TEAS PETITION TO DIRECTOR RECEIVED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 1 FILED
Monday, December 18, 2023SOU EXTENSION 1 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 26, 2024ASSIGNED TO PETITION STAFF
Thursday, February 29, 2024PETITION TO DIRECTOR DENIED
Thursday, May 9, 2024SOU EXTENSION 2 FILED
Thursday, May 9, 2024SOU EXTENSION 2 GRANTED
Thursday, May 9, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED